Skip to main content
European Commission logo
European Commission
  • Project

Pre-operational treatment and treatment of patients with pharmacoresistant epilepsy in General Hospital Dubrava

Pre-operational treatment and treatment of patients with pharmacoresistant epilepsy in General Hospital Dubrava
Copyright: Adobe Stock

The objective of this investment, which receives EUR 0.6 million from the Recovery and resilience facility, was to purchase and install ten state-of-the-art pieces of medical equipment and adapt the spatial capacity for some of the purchased devices in order to further develop the services of the Institute of Neurology in the Clinical center Dubrava as well as the pre-operational methods and treatments of epilepsy in pharmaco-resistant patients.

The investment covers the acquisition of equipment such as SEEG 256 canal recording devices, digital EMNG and EP 12 channel imaging device and radio Frequency (RF) thermocoagulation device.

Additional links: